Conflict Of Interest

Proposed guidelines kick industry off campus

Proposed guidelines kick industry off campus

By

Pew Charitable Trust's proposed conflict of interest guidelines could mean even less face time for sales reps and less industry money for CME programs.

Researchers find schools minting pitch-resistant docs

By

A BMJ study finds that medical school gift bans make doctors less likely to prescribe a new drug. Also of note: consumers think money motivates some doctors' recommendations.

CMS releases "Sunshine" final rule: federal preemption, August start date

CMS releases "Sunshine" final rule: federal preemption, August start date

By

CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.

GSK's Connelly: We've changed our ways (and please don't imprison execs)

GSK's Connelly: We've changed our ways (and please don't imprison execs)

By

GlaxoSmithKline's Dierdre Connelly peeled back the curtain on the company's sales force incentives revamp in a speech to the Pharmaceutical Regulatory and Compliance Congress, and pleaded for recognition that the industry had cleaned up the sketchy practices of the Blockbuster Era.

Medtronic defends physician ties IDed in Senate report

Medtronic defends physician ties IDed in Senate report

By

Medtronic rebuffed Senate Finance Committee charges that the company ghostwrote or influenced journal articles about its InFuse bone-growth product while conspiring to paper over adverse events from the treatment.

Docs downgrade results of pharma-funded clinical trials

By

Physicians take pharma-sponsored clinical trials with a grain of salt, a study published in The New England Journal of Medicine has found.

Sunshine Act could scare docs away from commercially-supported CME

Sunshine Act could scare docs away from commercially-supported CME

By

Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.

Makers of pain pills, advocacy groups at center of Senate probe

By

The Senate Finance Committee is looking to crack down on unnecessary pain prescriptions and is using a money trail to do it.

Journal "pharmascolds" skew policy, says study

By

Medical journal coverage of the question of physician-industry relationships is "unbalanced" and may be skewing public policy towards ever-more restrictive safeguards against industry influence.

Require disclosure of pharma ties, most docs say

Require disclosure of pharma ties, most docs say

By

The majority of physicians agrees that it's important to disclose to patients any financial relationships with drug and device companies but, research shows, there remains considerable rearguard sentiment to transparency.

Despite decline, ghostwriting in papers still common: study

By

Researchers analyzing the prevalence of ghostwriting in leading medical journals over more than a decade saw a decline but found inappropriate authorship remained all too common.

One fourth of family medicine residencies "pharma free," says survey

By

Most US family medicine resident programs have limits on drug industry interaction with doctors, and a quarter shun doctor-company contacts altogether, said a survey by Georgetown University Medical Center and the American Medical Student Association.

In stepping up COI rules, Yale takes 'rational' approach to industry

In stepping up COI rules, Yale takes 'rational' approach to industry

By

Yale School of Medicine, which created conflict-of-interest guidelines years ago, has made them binding for physicians in its faculty practice.

ACCME: Peer review, plus other provider controls, enable industry employees to present original research in CME

By

Several months' worth of dialogue, at times public and heated, between physician groups like the American Heart Association and the ACCME, has resulted in new guidance from the regulator of continuing medical education: Industry scientists, who had been barred from presenting original product-related research at for-credit talks, may now do so as long as provider controls ensure they have zero control over the content.

Physician leaders push back on policy barring industry speakers from talks

By

A policy barring pharmaceutical industry employees from giving continuing medical education talks at meetings has elicited strong opposition from physician leaders.

NIH still thinks universities make the best conflict watchdog

By

The nation's biggest funder of biomedical research has proposed several changes to its rules governing when and how investigators should disclose financial interests from industry.

Specialty societies' code targets conflicts of interest

By

Medical society journals must ban ghostwritten articles and cannot place ads for drugs next to editorial content discussing those products or their makers under a sweeping ethics code signed by several major medical societies.

FDA proposes more openness about advisors' financial ties

FDA proposes more openness about advisors' financial ties

By

The FDA announced a proposal to disclose more information about financial interests among its advisory committee members, while the agency's commissioner, Margaret Hamburg, offered some advice of her own, outlining steps for recruiting needed experts who have financial conflicts.

In protecting market research, federal exclusion may not always apply

In protecting market research, federal exclusion may not always apply

By

Thanks to the work of lobbyists, marketing research-related payments are explicitly excluded from Sunshine legislation enacted Tuesday as part of the healthcare overhaul. But the exclusion may not always apply.

New Jersey's tough new conflict regs face uncertain future

New Jersey's tough new conflict regs face uncertain future

By

Conflict-of-interest rules announced by New Jersey's Division of Consumer Affairs last week would seem to have mixed prospects under an incoming Republican administration.

Journal editors subject authors to greater scrutiny

By

Researchers submitting manuscripts to many medical journals will have to fill out a more probing disclosure form aimed at exposing potential conflicts of interest.

Fewer than 1% of docs sees bias in online CME, survey finds

By

A Medscape-sponsored survey of a million physicians participating in online CME found that fewer than 1% perceived bias, regardless of whether or not it was commercially-supported.

Nissen: ACCME should be abolished

By

The Accreditation Council for Continuing Medical Education is a toothless watchdog and should be abolished, said Cleveland Clinic's Dr. Steven Nissen at a Senate Committee on Aging hearing.

Email Newsletters